Worth Venture Partners, LLC Mirum Pharmaceuticals, Inc. Transaction History

Worth Venture Partners, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$15.5 - $23.93 $1.2 Million - $1.85 Million	-77,515 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$13.05 - $19.35 $1.01 Million - $1.5 Million	77,515 New	77,515 $1.24 Million
Q1 2021 May 17, 2021	SELL	$16.29 - $21.92 $267,481 - $359,926	-16,420 Closed	0 $0
Q4 2020 Feb 17, 2021	SELL	$15.75 - $25.45 $542,682 - $876,905	-34,456 Reduced 67.73%	16,420 $287,000
Q3 2020 Nov 16, 2020	SELL	$18.4 - $26.59 $41,860 - $60,492	-2,275 Reduced 4.28%	50,876 $980,000
Q2 2020 Aug 14, 2020	SELL	$11.51 - $20.97 $8,759 - $15,958	-761 Reduced 1.41%	53,151 $1.04 Million
Q1 2020 May 15, 2020	BUY	$9.38 - $23.79 $251,046 - $636,715	26,764 Added 98.59%	53,912 $755,000
Q4 2019 Feb 14, 2020	BUY	$6.84 - $25.9 $185,692 - $703,133	27,148 New	27,148 $666,000

190

54M

177K

167K

Ticker MIRM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,751,700
Market Cap $1.52B
Description
Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...

Get notified when there are updates to the investment portfolio of Worth Venture Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Worth Venture Partners, LLC with notifications on news.